These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12536690)

  • 1. [Changes in plasma concentration of interleukin-6 in elderly patients with coronary artery disease complicated with heart failure].
    Wang XQ; Jian ZJ; Xie JC
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):231-2. PubMed ID: 12536690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-13 levels in patients with chronic heart failure.
    Nishimura Y; Inoue T; Nitto T; Morooka T; Node K
    Int J Cardiol; 2009 Jan; 131(3):421-3. PubMed ID: 18031842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of plasma interleukin-18 and interferon-gamma in patients with coronary heart disease].
    Wang SF; Xu JC; Liang QX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):237-9. PubMed ID: 16647017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure.
    Wykretowicz A; Furmaniuk J; Smielecki J; Deskur-Smielecka E; Szczepanik A; Banaszak A; Wysocki H
    Int J Cardiol; 2004 Apr; 94(2-3):283-7. PubMed ID: 15093994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A
    Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.
    Suchanek H; Myśliwska J; Siebert J; Wieckiewicz J; Hak Ł; Szyndler K; Kartanowicz D
    Eur Cytokine Netw; 2005 Sep; 16(3):177-85. PubMed ID: 16266856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease.
    Hudzik B; Szkodzinski J; Romanowski W; Danikiewicz A; Wilczek K; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    Cytokine; 2011 Jun; 54(3):266-71. PubMed ID: 21382729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
    Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
    J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum adiponectin level in patients of chronic pulmonary heart disease with cardiac failure].
    Shi HF; Ding YP; He HW
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2544-6. PubMed ID: 19080646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
    Málek F; Dvorák J; Jiresová E; Spacek R
    Cent Eur J Public Health; 2003 Dec; 11(4):198-201. PubMed ID: 14768782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect on endothelin and cytokines on the pathogenesis of coronary heart disease].
    Guan Y; Zhang M; Yuan H; Yang J; Wang J
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):569-71. PubMed ID: 10806772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S; Adamopoulos S; Parissis JT; Rassias J; Kostakis G; Iliodromitis E; Degiannis D; Kremastinos DT
    Int J Cardiol; 2005 Mar; 99(3):409-13. PubMed ID: 15771921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure.
    Suzuki H; Sato R; Sato T; Shoji M; Iso Y; Kondo T; Shibata M; Koba S; Katagiri T
    Int J Cardiol; 2005 Apr; 100(3):415-20. PubMed ID: 15837085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers and heart rate variability in women with coronary heart disease.
    Janszky I; Ericson M; Lekander M; Blom M; Buhlin K; Georgiades A; Ahnve S
    J Intern Med; 2004 Nov; 256(5):421-8. PubMed ID: 15485478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between sTNFR-I and other negative prognostic factors in patients with chronic heart failure.
    Pop D; Zdrenghea D; Cebanu M; Borz B
    Rom J Intern Med; 2007; 45(3):243-9. PubMed ID: 18333356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.